These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9402946)

  • 1. Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction.
    Li AP; Maurel P; Gomez-Lechon MJ; Cheng LC; Jurima-Romet M
    Chem Biol Interact; 1997 Nov; 107(1-2):5-16. PubMed ID: 9402946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.
    Li AP; Reith MK; Rasmussen A; Gorski JC; Hall SD; Xu L; Kaminski DL; Cheng LK
    Chem Biol Interact; 1997 Nov; 107(1-2):17-30. PubMed ID: 9402947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
    Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes.
    Masubuchi N; Li AP; Okazaki O
    Chem Biol Interact; 1998 Jul; 114(1-2):1-13. PubMed ID: 9744552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refinement of an in vitro cell model for cytochrome P450 induction.
    Silva JM; Morin PE; Day SH; Kennedy BP; Payette P; Rushmore T; Yergey JA; Nicoll-Griffith DA
    Drug Metab Dispos; 1998 May; 26(5):490-6. PubMed ID: 9571231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cytochrome P450 3A (CYP 3A) by E 5110, a non-steroidal anti-inflammatory agent (NSAID), and typical CYP 3A inducers in primary cultures of dog hepatocytes.
    Nishibe Y; Hirata M
    Biol Pharm Bull; 1995 Aug; 18(8):1142-4. PubMed ID: 8535412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.
    Li AP; Lu C; Brent JA; Pham C; Fackett A; Ruegg CE; Silber PM
    Chem Biol Interact; 1999 Jun; 121(1):17-35. PubMed ID: 10418968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of HepaRG and human hepatocyte data in predicting CYP induction drug-drug interactions via static equation and dynamic mechanistic modelling approaches.
    Grime K; Ferguson DD; Riley RJ
    Curr Drug Metab; 2010 Dec; 11(10):870-85. PubMed ID: 21208171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
    Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
    Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.
    Garcia M; Rager J; Wang Q; Strab R; Hidalgo IJ; Owen A; Li J
    In Vitro Cell Dev Biol Anim; 2003; 39(7):283-7. PubMed ID: 14599235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated triplexed hepatocyte-based viability and CYP1A and -3A induction assays.
    Larson B; Moeller T; Banks P; Cali JJ
    J Biomol Screen; 2011 Sep; 16(8):895-902. PubMed ID: 21693767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
    Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs).
    Ronis MJ; Ingelman-Sundberg M; Badger TM
    Biochem Pharmacol; 1994 Nov; 48(10):1953-65. PubMed ID: 7986207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-laboratory evaluation of the response of primary human hepatocyte cultures to model CYP inducers - a European Centre for Validation of Alternative Methods (ECVAM) - funded pre-validation study.
    Richert L; Abadie C; Bonet A; Heyd B; Mantion G; Alexandre E; Bachellier P; Kingston S; Pattenden C; Illouz S; Dennison A; Hoffmann S; Coecke S
    Toxicol In Vitro; 2010 Feb; 24(1):335-45. PubMed ID: 19497361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics.
    Choi JM; Oh SJ; Lee SY; Im JH; Oh JM; Ryu CS; Kwak HC; Lee JY; Kang KW; Kim SK
    Arch Pharm Res; 2015; 38(5):691-704. PubMed ID: 25336106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytochrome P450 enzymes in primary equine hepatocyte culture.
    Stefanski A; Mevissen M; Möller AM; Kuehni-Boghenbor K; Schmitz A
    Toxicol In Vitro; 2013 Oct; 27(7):2023-30. PubMed ID: 23916975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 expression profile of the PICM-19H pig liver cell line: potential application to rapid liver toxicity assays.
    Willard RR; Shappell NW; Meekin JH; Talbot NC; Caperna TJ
    In Vitro Cell Dev Biol Anim; 2010 Jan; 46(1):11-9. PubMed ID: 19915937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug metabolism in hepatocyte sandwich cultures of rats and humans.
    Kern A; Bader A; Pichlmayr R; Sewing KF
    Biochem Pharmacol; 1997 Oct; 54(7):761-72. PubMed ID: 9353130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities and challenges in using human hepatocytes in cytochromes P450 induction assays.
    Dvorak Z
    Expert Opin Drug Metab Toxicol; 2016; 12(2):169-74. PubMed ID: 26612411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.